Patients suffering from a rare degenerative brain disease might soon lose funding for an expensive drug that a leading neurologist says could partially alleviate some of the effects of the disease.
The Department of Health's (DOH) committee on rare diseases decided last month that there is not enough evidence showing that Miglustat, the drug marketed as Zavesca, is effective in treating Niemann-Pick disease, a rare inherited disorder with no cure. The disease is fatal and usually strikes in childhood or adolescence, occurring in roughly one out of every 150,000 individuals.
Department officials said that there will be another expanded advisory committee meeting on this matter once the drug's maker and other experts submit more evidence on the effectiveness of Zavesca.
Currently, 50 percent of the cost is subsidized by the Bureau of Health Promotion pending an expanded advisory committee meeting on the issue. The other 50 percent is currently provided by a social welfare fund from National Taiwan University.
Hu Wu-liang (胡務亮), a physician at National Taiwan University Hospital's medical genetics department and a member of the committee on rare diseases, is strongly against the committee's decision. Hu is the doctor who first prescribed Zavesca for patients with Niemann-Pick disease in Taiwan.
Speaking to the Central News Agency, Hu said that from his clinical experience, Zavesca has helped halt the pace of deterioration in Niemann-Pick patients and even helped some patients regain the ability to swallow food.
There is no other drug out there for Niemann-Pick patients, Hu said.
However, Bureau of Pharmaceutical Affairs Director Liao Chi-chou (廖繼洲) said neither Zavesca's maker, Swiss biotech firm Actelion nor the team at the hospital have provided enough evidence showing that Zavesca actually works.
"The company only provided the result of a 29 patient study." Liao said.
"The study showed that patients taking Zavesca actually did worse than the control group by many measures," Liao said.
Liao said that he respects Hu's observations, but that the committee can only make their decision based on scientific evidence.
"I hope that both the company and the hospital submit more information soon so that the expanded advisory committee can meet and properly evaluate the effectiveness of Zavesca," Liao said.
Until the expanded committee makes a decision, the BHP will continue to subsidize 50 percent of the cost for Zavesca for Niemann-Pick patients. Zavesca costs roughly NT$320,000 per patient per month.
Last month, the European Committee for Medicinal Products for Human Use issued a negative opinion on the use of Miglustat for Niemann-Pick patients. Reuters reports that Actelion intends to ask for a re-examination of that opinion.
Former president Tsai Ing-wen (蔡英文) on Monday called for greater cooperation between Taiwan, Lithuania and the EU to counter threats to information security, including attacks on undersea cables and other critical infrastructure. In a speech at Vilnius University in the Lithuanian capital, Tsai highlighted recent incidents in which vital undersea cables — essential for cross-border data transmission — were severed in the Taiwan Strait and the Baltic Sea over the past year. Taiwanese authorities suspect Chinese sabotage in the incidents near Taiwan’s waters, while EU leaders have said Russia is the likely culprit behind similar breaches in the Baltic. “Taiwan and our European
The Taipei District Court sentenced babysitters Liu Tsai-hsuan (劉彩萱) and Liu Jou-lin (劉若琳) to life and 18 years in prison respectively today for causing the death of a one-year-old boy in December 2023. The Taipei District Prosecutors’ Office said that Liu Tsai-hsuan was entrusted with the care of a one-year-old boy, nicknamed Kai Kai (剴剴), in August 2023 by the Child Welfare League Foundation. From Sept. 1 to Dec. 23 that year, she and her sister Liu Jou-lin allegedly committed acts of abuse against the boy, who was rushed to the hospital with severe injuries on Dec. 24, 2023, but did not
LIKE-MINDED COUNTRIES: Despite the threats from outside, Taiwan and Lithuania thrived and developed their economies, former president Tsai Ing-wen said Former president Tsai Ing-wen (蔡英文) on Saturday thanked Lithuania for its support of Taiwan, saying that both countries are united as partners in defending democracy. Speaking at a reception organized by the Lithuania-Taiwan Parliamentary Friendship Group welcoming her on her first visit to the Baltic state, Tsai said that while she was president from 2016 to last year, many Lithuanian “friends” visited Taiwan. “And I told myself I have to be here. I am very happy that I am here, a wonderful country and wonderful people,” Tsai said. Taiwan and Lithuania are in similar situations as both are neighbors to authoritarian countries, she
Former president Tsai Ing-wen (蔡英文) is to visit the UK during her ongoing European trip, which originally included only Lithuania and Denmark, her office said today. Tsai departed Taiwan for Europe on Friday night, with planned stops in Lithuania and Denmark, marking her second visit to the continent since her two-term presidency ended in May last year. Her office issued a statement today saying that Tsai would also visit the UK "for a few days," during which she is to meet with UK politicians and Taiwanese professionals, and visit academic and research institutions. Following Tsai's stop in Denmark, she is to visit the
RSS